Covid-19: Campaigners accuse Pfizer of blocking access to antiviral for trials in poorer countries. Thornton J. BMJ 2022;376:o721.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Thornton J. Covid-19: Campaigners accuse Pfizer of blocking access to antiviral for trials in poorer countries. BMJ 2022;376:o721.
PMID: 35301222